GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 24464
Submission : 2010-12-17
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35897
Submission : 2021-05-21
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 9822
Submission : 1992-08-14
Status : Inactive
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26232
Submission : 2012-07-13
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26231
Submission : 2012-07-13
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3696
Submission : 1980-01-28
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 28836
Submission : 2014-11-07
Status : Active
Type : IV

USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37535
Submission : 2022-11-30
Status : Active
Type : IV

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]About the Company : Lead Sciences supports researchers in Life Sciences and Clinical Diagnostics by offering high-quality reagents, instruments, custom manufacturing, and testing services. Our unique ...

About the Company : SIDLEYCHEM has focused on the application development and product promotion of construction chemicals such as mortars and coating additives for many years. To provide customers wit...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FINISHED DOSAGE FORMULATIONS
Drug : FETZIMA
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 204168
Country : US
Patented : Yes
Drug : URSO FORTE
Dosage Form : TABLET; ORAL
Application Number : 20675
Country : US
Patented : No
Drug : K-TAB
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 18279
Country : US
Patented : No
Drug : URSO 250
Dosage Form : TABLET; ORAL
Application Number : 20675
Country : US
Patented : No
Drug : KADIAN
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 20616
Country : US
Patented : No
Drug : DILACOR XR
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 20092
Country : US
Patented : No
ESTROGENS, CONJUGATED SYNTHETIC B
Drug : ENJUVIA
Dosage Form : TABLET; ORAL
Application Number : 21443
Country : US
Patented : No
Drug : SIROLIMUS
Dosage Form : TABLET; ORAL
Application Number : 201578
Country : US
Patented : No
Drug : METOPROLOL SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 78889
Country : US
Patented : No
Drug : ERRIN
Dosage Form : TABLET; ORAL-28
Application Number : 76225
Country : US
Patented : No
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EXCIPIENTS BY APPLICATIONS
MARKET PLACE
REF. STANDARDS & IMPURITIES